News

COPAN Diagnostics, a company committed to new innovations and education in the field of preanalytics, launches a newly redesigned website. The website Copanusa.com aims to improve COPAN’s online brand and features various enhancements visitors to the site will enjoy.

FecalSwab™ simplifies and standardizes fecal sample collection, transport and processing by converting solid or semi-solid fecal specimens into a phase suitable for fully automatic specimen processors, in space saving, instrument ready tubes. FecalSwab™ provides a compact and neat alternative to traditional large, bulky transport containers, which collect a quantity far greater than needed for culture or molecular testing.

Notably these two new US patents, US 8,979,784 and US 9,011,358, have a broad scope of protection for the flocked swab device, in addition to the method of use of such device previously covered by the first two US patents. COPAN is in a strong position to legally stop any infringing activity, such as manufacturing, promoting and selling, including exporting from the US to other countries, flocked swabs covered by the patent claims.

The distinctive VI-PAK metallic appearance is due to the high-tech composite of metallic foil and barrier plastic film proven to provide the ultimate product protection and shelf life stability. It creates a closed system for maintaining optimum performance of the medium over its long shelf life.

COPAN Group announces with great sadness that, on July 30th, 2014, its beloved, charismatic and eclectic leader, Daniele Triva passed away at his home in Italy, after a seven-month battle with Esophageal Gastric cancer. Daniele was 54 years old and…

Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system.

UTM™ is a cross-platform medium proven to be good for viruses, as well as Bordetella. COPAN’s complete array of products have a proven track record, through numerous clinical and scientific publications, demonstrating their high quality and reliability. COPAN has experience responding to epidemics, like Whooping Cough, by producing products for specimen collection and transport in a timely manner.

OPAN and MetaSystems GmbH are pleased to announce they have signed a global and exclusive agreement for the integration of automatic microscopy slide scanning system, provided by MetaSystems, with WASPLab™.

COPAN Diagnostics, Inc. announced today a distribution agreement for COPAN WASP^®: Walk-Away Specimen Processor with Thermo Fisher Scientific Inc. in the United States.

During the 2009 H1N1 outbreak, COPAN invested tremendously in production capacity to meet the global demand, so we are more than prepared to handle the increased demand we are seeing now” says Norman Sharples, CEO of COPAN Diagnostics, Inc. “As the leader in collection and transport systems, we have the infrastructure needed to meet the demand in a timely manner.